About This 510(k) Submission
K991078 is an FDA 510(k) clearance for the ACCUSIGN DOA8, DOA8 PANEL, THC/OPI/COC/AMP/BZO/BAR/TCA/PCP, BIOSIGN DOA8, THC/OPI/COC/AMP/BZO/BAR/TCA/PAP, STATUS DS DO8, a Reagents, Test, Tetrahydrocannabinol (Class II — Special Controls, product code DKE), submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on April 15, 1999, 20 days after receiving the submission on March 26, 1999. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3870.